TRU BLOCK ULTRA Trademark

Trademark Overview

On Thursday, August 31, 2017, a trademark application was filed for TRU BLOCK ULTRA with the United States Patent and Trademark Office. The USPTO has given the TRU BLOCK ULTRA trademark a serial number of 87591321. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, October 23, 2024. This trademark is owned by Meridian Bioscience, Inc.. The TRU BLOCK ULTRA trademark is filed in the Pharmaceutical Products category with the following description:

Biological reagents to block heterophilic antibodies in immunoassays for medical purposes
tru block ultra

General Information

Serial Number87591321
Word MarkTRU BLOCK ULTRA
Filing DateThursday, August 31, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, October 23, 2024
Registration Number5740608
Registration DateTuesday, April 30, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 26, 2017

Trademark Statements

Goods and ServicesBiological reagents to block heterophilic antibodies in immunoassays for medical purposes
NOT AVAILABLE"BLOCK"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 8, 2017
Primary Code005
First Use Anywhere DateMonday, July 31, 2017
First Use In Commerce DateMonday, July 31, 2017

Trademark Owner History

Party NameMeridian Bioscience, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45244
Party NameMeridian Bioscience, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45244
Party NameMeridian Bioscience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45244

Trademark Events

Event DateEvent Description
Wednesday, November 15, 2017ASSIGNED TO LIE
Monday, September 4, 2017NEW APPLICATION ENTERED
Friday, September 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 30, 2017ASSIGNED TO EXAMINER
Friday, November 3, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, November 3, 2017EXAMINERS AMENDMENT E-MAILED
Friday, November 3, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 3, 2017EXAMINER'S AMENDMENT ENTERED
Monday, November 6, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 26, 2018NON-FINAL ACTION E-MAILED
Wednesday, December 6, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 26, 2017PUBLISHED FOR OPPOSITION
Tuesday, December 26, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 31, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, July 31, 2018USE AMENDMENT FILED
Tuesday, August 28, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 28, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 26, 2018SU - NON-FINAL ACTION - WRITTEN
Wednesday, September 26, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 22, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 27, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 27, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 27, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 28, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 30, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, April 30, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 30, 2024TEAS SECTION 8 & 15 RECEIVED
Wednesday, October 23, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 23, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, October 23, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

ultra block immunoassays medical purposes antibodies heterophilic reagents biological